Table 1.
Age | Gender | Ischaemia time | ||||||
---|---|---|---|---|---|---|---|---|
(years) | Male | Female | Diseases | (n) | Race | (n) | (min) | |
LRD | 14·5 ± 0·9 | 6 | 6 | Obstruction | 3 | Caucasian | 3 | |
Dysplasia | 2 | Hispanic | 4 | |||||
GN | 3 | African American | 5 | ≤30 | ||||
FSGS | 4 | |||||||
CAD | 13·5 ± 0·9 | 6 | 7 | Obstruction | 4 | Caucasian | 3 | |
Dysplasia | 4 | Hispanic | 4 | |||||
GN | 3 | African American | 6 | 1395 ± 77 | ||||
FSGS | 2 |
FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis.